{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:59:43Z","timestamp":1790413183980,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000344","name":"Shine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000344","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN-216927"],"award-info":[{"award-number":["FRN-216927"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.yjmcc.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T12:59:32Z","timestamp":1554814772000},"page":"151-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["Histone deacetylases in cardiovascular and metabolic diseases"],"prefix":"10.1016","volume":"130","author":[{"given":"Rushita A.","family":"Bagchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4844-6437","authenticated-orcid":false,"given":"Kate L.","family":"Weeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2019.04.003_bb0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","article-title":"Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy","volume":"110","author":"Zhang","year":"2002","journal-title":"Cell."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/jpet.111.189910","article-title":"Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis","volume":"341","author":"Zhang","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0015","doi-asserted-by":"crossref","first-page":"H968","DOI":"10.1152\/ajpheart.00891.2006","article-title":"Inhibition of histone deacetylase on ventricular remodeling in infarcted rats","volume":"293","author":"Lee","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0020","doi-asserted-by":"crossref","first-page":"H1391","DOI":"10.1152\/ajpheart.00390.2014","article-title":"Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction","volume":"308","author":"Mani","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0025","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1096\/fj.08-108548","article-title":"Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice","volume":"22","author":"Granger","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0030","doi-asserted-by":"crossref","first-page":"H2154","DOI":"10.1152\/ajpheart.01015.2009","article-title":"Targeted deletion of NF-\u03baB p50 diminishes the cardioprotection of histone deacetylase inhibition","volume":"298","author":"Zhang","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0035","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.113.002416","article-title":"Histone deacetylase inhibition blunts ischemia\/reperfusion injury by inducing cardiomyocyte autophagy","volume":"129","author":"Xie","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0045","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","article-title":"Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy","volume":"113","author":"Kong","year":"2006","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/cvr\/cvn215","article-title":"Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure","volume":"80","author":"Gallo","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0055","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1253\/circj.CJ-09-0580","article-title":"Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats","volume":"74","author":"Cho","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12933-015-0262-8","article-title":"Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice","volume":"14","author":"Chen","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0065","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbrc.2018.04.090","article-title":"HDAC11 deletion reduces fructose-induced cardiac dyslipidemia, apoptosis and inflammation by attenuating oxidative stress injury","volume":"503","author":"Fan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0070","doi-asserted-by":"crossref","first-page":"17335","DOI":"10.1073\/pnas.0706487104","article-title":"Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases","volume":"104","author":"Lahm","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0075","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1093\/emboj\/18.18.5099","article-title":"HDAC4 deacetylase associates with and represses the MEF2 transcription factor","volume":"18","author":"Miska","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0080","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.1128\/MCB.22.20.7302-7312.2002","article-title":"Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation","volume":"22","author":"Zhang","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0085","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/nar\/30.5.1114","article-title":"Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain","volume":"30","author":"Tong","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0090","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.272.5260.408","article-title":"A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p","volume":"272","author":"Taunton","year":"1996","journal-title":"Science."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0095","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1073\/pnas.93.23.12845","article-title":"Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3","volume":"93","author":"Yang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0100","doi-asserted-by":"crossref","first-page":"28001","DOI":"10.1074\/jbc.272.44.28001","article-title":"Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family","volume":"272","author":"Yang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0105","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","article-title":"Three proteins define a class of human histone deacetylases related to yeast Hda1p","volume":"96","author":"Grozinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1101\/gad.14.1.55","article-title":"Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression","volume":"14","author":"Kao","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2006.05.040","article-title":"Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10","volume":"126","author":"Chang","year":"2006","journal-title":"Cell."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0120","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.117.028252","article-title":"Multicellular transcriptional analysis of mammalian heart regeneration","volume":"136","author":"Quaife-Ryan","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0130","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","article-title":"Sirtuins and NAD+ in the development and treatment of metabolic and cardiovascular diseases","volume":"123","author":"Kane","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature01411","article-title":"Controlling the double helix","volume":"421","author":"Felsenfeld","year":"2003","journal-title":"Nature."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0140","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24570","article-title":"EED orchestration of heart maturation through interaction with HDACs is H3K27me3-independent","volume":"6","author":"Ai","year":"2017","journal-title":"eLife."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(01)00429-4","article-title":"Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT\/N-CoR","volume":"9","author":"Fischle","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0150","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI61084","article-title":"HDAC4 controls histone methylation in response to elevated cardiac load","volume":"123","author":"Hohl","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15368","article-title":"Histone deacetylase 10 structure and molecular function as a polyamine deacetylase","volume":"8","author":"Hai","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2018.04.007","article-title":"Histone deacetylase 11 is an \u03b5-N-myristoyllysine hydrolase","volume":"25","author":"Moreno-Yruela","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0165","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1021\/acschembio.7b00942","article-title":"Histone deacetylase 11 is a fatty-acid deacylase","volume":"13","author":"Kutil","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0170","doi-asserted-by":"crossref","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0175","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1074\/jbc.M107942200","article-title":"Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70","volume":"277","author":"Johnson","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0180","doi-asserted-by":"crossref","first-page":"15254","DOI":"10.1074\/jbc.M908988199","article-title":"Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor","volume":"275","author":"Hu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0185","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1074\/jbc.M115.653048","article-title":"Histone deacetylase 3 (HDAC3)-dependent reversible lysine acetylation of cardiac myosin heavy chain isoforms modulates their enzymatic and motor activity","volume":"290","author":"Samant","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao0144","article-title":"Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism","volume":"10","author":"Jeong","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0195","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0200","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/35042612","article-title":"Deacetylation of p53 modulates its effect on cell growth and apoptosis","volume":"408","author":"Luo","year":"2000","journal-title":"Nature."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0205","doi-asserted-by":"crossref","first-page":"20436","DOI":"10.1074\/jbc.M000202200","article-title":"Histone deacetylases specifically down-regulate p53-dependent gene activation","volume":"275","author":"Juan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0210","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0215","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.114.008720","article-title":"Global and regional patterns in cardiovascular mortality from 1990 to 2013","volume":"132","author":"Roth","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0220","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives","volume":"8","author":"Chen","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0225","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/jpet.116.234591","article-title":"Class I histone deacetylase inhibition for the treatment of sustained atrial fibrillation","volume":"358","author":"Seki","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0230","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/CIRCULATIONAHA.113.005300","article-title":"Activation of histone deacetylase-6 induces contractile dysfunction through derailment of \u03b1-tubulin proteostasis in experimental and human atrial fibrillation","volume":"129","author":"Zhang","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097260","article-title":"Histone deacetylase inhibitor treatment increases coronary t-PA release in a porcine ischemia model","volume":"9","author":"Svennerholm","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0240","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0245","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0250","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI19137","article-title":"Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop","volume":"112","author":"Kook","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0255","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1113\/jphysiol.2014.282442","article-title":"Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms","volume":"593","author":"Weeks","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0260","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm1552","article-title":"Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3\u03b2 activity","volume":"13","author":"Trivedi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0265","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gad.1563807","article-title":"Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility","volume":"21","author":"Montgomery","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0270","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/MCB.00639-15","article-title":"Essential nonredundant function of the catalytic activity of histone deacetylase 2 in mouse development","volume":"36","author":"Hagelkruys","year":"2016","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0275","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1172\/JCI35847","article-title":"Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice","volume":"118","author":"Montgomery","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0280","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/MCB.00882-06","article-title":"Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2","volume":"27","author":"Gregoire","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0290","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI27438","article-title":"CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy","volume":"116","author":"Backs","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0295","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1128\/MCB.24.24.10636-10649.2004","article-title":"The CRM1 nuclear export receptor controls pathological cardiac gene expression","volume":"24","author":"Harrison","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0300","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1073\/pnas.080064097","article-title":"Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases","volume":"97","author":"Lu","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0305","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1128\/MCB.24.19.8374-8385.2004","article-title":"Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5","volume":"24","author":"Vega","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0310","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.4452","article-title":"A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway","volume":"24","author":"Lehmann","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0315","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.24.19.8467-8476.2004","article-title":"Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development","volume":"24","author":"Chang","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0320","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1073\/pnas.140199597","article-title":"Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization","volume":"97","author":"Grozinger","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0325","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1128\/MCB.21.18.6312-6321.2001","article-title":"Identification of a signal-responsive nuclear export sequence in class II histone deacetylases","volume":"21","author":"McKinsey","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0330","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1128\/MCB.26.10.3875-3888.2006","article-title":"Regulation of cardiac stress signaling by protein kinase D1","volume":"26","author":"Harrison","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0335","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCRESAHA.107.169755","article-title":"Ca2+\/calmodulin-dependent protein kinase II\u03b4 and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure","volume":"102","author":"Bossuyt","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0340","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1172\/JCI27374","article-title":"Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling","volume":"116","author":"Wu","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0345","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/MCB.01611-07","article-title":"Histone deacetylase 5 acquires calcium\/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4","volume":"28","author":"Backs","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0350","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004861","article-title":"\u03b2-Adrenergic stimulation induces histone deacetylase 5 (HDAC5) nuclear accumulation in cardiomyocytes by B55\u03b1-PP2A-mediated dephosphorylation","volume":"6","author":"Weeks","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0355","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1073\/pnas.0337639100","article-title":"Regulation of peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1 (PGC-1\u03b1) and mitochondrial function by MEF2 and HDAC5","volume":"100","author":"Czubryt","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yjmcc.2011.04.005","article-title":"Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension","volume":"51","author":"Lemon","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0365","doi-asserted-by":"crossref","first-page":"H252","DOI":"10.1152\/ajpheart.00149.2014","article-title":"HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling","volume":"307","author":"Demos-Davies","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0370","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2014.03.005","article-title":"Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion","volume":"72","author":"Aune","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0375","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cvr\/cvu254","article-title":"miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8","volume":"105","author":"Yan","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0380","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.yjmcc.2014.02.015","article-title":"Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs","volume":"70","author":"Schuetze","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0385","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2013.12.013","article-title":"Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes","volume":"67","author":"Williams","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0390","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-7-10","article-title":"HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation","volume":"7","author":"Nural-Guvener","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0395","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/jpet.116.237701","article-title":"Overlapping and divergent actions of structurally distinct histone deacetylase inhibitors in cardiac fibroblasts","volume":"361","author":"Schuetze","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0400","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1016\/j.ijcard.2013.07.111","article-title":"Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure","volume":"168","author":"Kao","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0405","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000438864","article-title":"Novel histone deacetylase inhibitor modulates cardiac peroxisome proliferator-activated receptors and inflammatory cytokines in heart failure","volume":"96","author":"Lkhagva","year":"2015","journal-title":"Pharmacology."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0410","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4196\/kjpp.2016.20.5.477","article-title":"Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats","volume":"20","author":"Lee","year":"2016","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0415","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000438781","article-title":"HDAC6 promotes cardiac fibrosis progression through suppressing RASSF1A expression","volume":"133","author":"Tao","year":"2016","journal-title":"Cardiology."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0420","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrcardio.2016.185","article-title":"Inflammatory processes in cardiovascular disease: a route to targeted therapies","volume":"14","author":"Ruparelia","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0425","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0430","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2018.04.011","article-title":"HDAC inhibition helps post-MI healing by modulating macrophage polarization","volume":"119","author":"Kimbrough","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0435","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0440","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/JME-14-0066","article-title":"Inhibition of HDAC3 promotes ligand-independent PPAR\u03b3 activation by protein acetylation","volume":"53","author":"Jiang","year":"2014","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0445","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1210\/en.2010-0828","article-title":"Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation","volume":"152","author":"Zhang","year":"2011","journal-title":"Endocrinology."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0450","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.2337\/diabetes.53.5.1208","article-title":"Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle","volume":"53","author":"McGee","year":"2004","journal-title":"Diabetes."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0455","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2337\/db07-0843","article-title":"AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5","volume":"57","author":"McGee","year":"2008","journal-title":"Diabetes."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0460","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1016\/j.celrep.2016.08.005","article-title":"Disruption of the class IIa HDAC corepressor complex increases energy expenditure and lipid oxidation","volume":"16","author":"Gaur","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0465","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/dom.12896","article-title":"Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice","volume":"19","author":"Gaur","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0470","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.numecd.2018.02.019","article-title":"Maternal high fat diet induces early cardiac hypertrophy and alters cardiac metabolism in Sprague Dawley rat offspring","volume":"28","author":"De Jong","year":"2018","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0475","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2337\/db13-1148","article-title":"HDAC9 knockout mice are protected from adipose tissue dysfunction and systemic metabolic disease during high-fat feeding","volume":"63","author":"Chatterjee","year":"2014","journal-title":"Diabetes."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0480","doi-asserted-by":"crossref","first-page":"27836","DOI":"10.1074\/jbc.M111.262964","article-title":"Histone deacetylase 9 is a negative regulator of adipogenic differentiation","volume":"286","author":"Chatterjee","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0485","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120159","article-title":"HDAC11 suppresses the thermogenic program of adipose tissue via BRD2","volume":"3","author":"Bagchi","year":"2018","journal-title":"JCI Insight."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0490","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2018.06.025","article-title":"Programming and regulation of metabolic homeostasis by HDAC11","volume":"33","author":"Sun","year":"2018","journal-title":"EBioMedicine."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0495","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0500","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"71","author":"Marwick","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0505","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0510","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/jcb.25902","article-title":"Sodium butyrate protects against high fat diet-induced cardiac dysfunction and metabolic disorders in type II diabetic mice","volume":"118","author":"Zhang","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0515","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/j.2040-4603.2016.tb00680.x","article-title":"Glucose transporters in cardiac metabolism and hypertrophy","volume":"6","author":"Shao","year":"2015","journal-title":"Compr Physiol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0520","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1172\/JCI117823","article-title":"Glycemic improvement in diabetic db\/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4)","volume":"95","author":"Gibbs","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0525","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1254\/jjp.78.63","article-title":"Effect of recombinant human insulin-like growth factor-I on expression of glucose transporters, GLUT 2 and GLUT 4, in streptozotocin-diabetic rat","volume":"78","author":"Asada","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0530","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.1074\/jbc.M800481200","article-title":"GLUT4 enhancer factor (GEF) interacts with MEF2A and HDAC5 to regulate the GLUT4 promoter in adipocytes","volume":"283","author":"Sparling","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0535","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1074\/jbc.M110.157107","article-title":"Class II histone deacetylases limit GLUT4 gene expression during adipocyte differentiation","volume":"286","author":"Weems","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0540","doi-asserted-by":"crossref","first-page":"14285","DOI":"10.1074\/jbc.273.23.14285","article-title":"Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes","volume":"273","author":"Thai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0545","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/JME-12-0095","article-title":"Histone deacetylase 5 regulates glucose uptake and insulin action in muscle cells","volume":"49","author":"Raichur","year":"2012","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0550","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.1021\/jm401053m","article-title":"Investigating the selectivity of metalloenzyme inhibitors","volume":"56","author":"Day","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yjmcc.2019.04.003_bb0555","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.lfs.2008.03.004","article-title":"The use of diversity profiling to characterize chemical modulators of the histone deacetylases","volume":"82","author":"Blackwell","year":"2008","journal-title":"Life Sci."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281831232X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281831232X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:28:15Z","timestamp":1758313695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002228281831232X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":111,"alternative-id":["S002228281831232X"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.04.003","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylases in cardiovascular and metabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}